Final-Program-ATS-2023-AP.vp

160

MONDAY • MAY 22

P1207 A Comparison of a Host-response Test and an Electronic Health Record Model as Diagnostic Aids and Risk Stratification Tools for Sepsis/ J.D. Bradford, Baton Rouge, LA P1208 Diagnostic Criteria and Inflammatory Markers for Sepsis as Predictors of Clinical Outcome: A Retrospective Study/ H. Lee, Brooklyn, NY P1209 The Effect of Empirical Treatment With Meropenem and Vancomycin in Sepsis Patients: A Retrospective Study/ H. Lee, Brooklyn, NY P1210 Comparison of Systemic Inflammatory Response Syndrome Criteria (SIRS) and Sepsis 3 Criteria for Assessing Outcomes in Sepsis: A Prospective Observational Study/ M.K. Daga, Delhi, India P1211 Outcomes After Early Hypotension in Sepsis: A Retrospective Cohort Study/ C. Chessare, Charlottesville, VA P1212 Multiomic, Mass Spectrometry-based Analysis of Dried Blood: Toward Deep Phenotyping of Sepsis/ M.W. Foster, Durham, NC P1213 Got MAP 65mm Hg, What Next?: Increased Inhospital Mortality With Elevated Central Venous Pressure/ J. Ninan, Rochester, MN P1214 Weight Based Fluid Resuscitation in Obese Patients With Sepsis and Septic Shock/ A. Saha, Worcester, MA P1215 Determining the Association Between the Origin of Sepsis and Severity of Sepsis in ICU Patients Using Apache IV Score/ A.J. Arumairaj, New York, NY P1216 ABO Blood Type Is Not Associated With Increased Risk of Septic Shock in Intensive Care Unit Patients With Sepsis/ V. Bansal, Jacksonville, FL P1217 Clinical Context From the Medical Record Improves Artificial Intelligence Models for Sepsis Prediction/ A. Holder, Atlanta, GA P1218 Association of Blood Culture-positive Pathogens With Outcomes in Community Onset Sepsis in the Intensive Care Unit/ T. Ohnuma, Durham, NC P1219 C-type Natriuretic Peptide Attenuates Endothelial and Cardiac Dysfunction During Endotoxemia and Polymicrobial Sepsis/ A. Moyes, London, United Kingdom P1220 Use of Beta-lactam Antibiotics in the Management of Sepsis in the Intensive Care Unit/ M. Horn, St. Louis, MO P1221 Are Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Associated With Improved Outcomes in Diabetic Patients Admitted to Intensive Care Unit (ICU) With Septic Shock?/ N. Ashcherkin, Scottsdale, AZ P1222 White Blood Cell Population Data Improves Identification of Sepsis in Hospitalized Adults: A Retrospective Cohort Study/ A. Barros, Charlottesville, VA

P871 Point of Care Lactate as a Predictor of 7day Morbidity and Mortality in Critically Ill Patients Presenting to the Emergency Department in Kenyatta National Hospital/ P.M. Mutuku, Nairobi, Kenya P872 Survival Predictions Among Physicians and Surrogates of Mechanically Ventilated Patients at Two ICU Time Points/ B. Dufour, Chicago, IL P873 Outcomes of Virtual Intensive Care Consults for an Academic Tertiary Care Center During COVID-19/ D. Decicco, Morgantown, WV P874 Incidence and Risk Factors of 30 Days Readmissions Following Hospitalization for Pneumonia in a Large Academic Medical Center/ K.Z. Abbas, Cleveland, OH P875 Linking Sepsis With Chronic Non-communicable Diseases and Socioeconomic Factors: A Systematic Review/ C.D. Ahlberg, Baltimore, MD P876 Outcomes With Early Rehabilitation in Post-Intensive Care Syndrome (PICS): A Systematic Review and Meta-Analysis/ R. Sharma, WIlkes-Barre, PA

CLINICAL THEMATIC POSTER SESSION

B45

NEW STUDIES IN SEPSIS AND INFECTIOUS DISEASES

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area L, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P1201 Treatment and Outcomes of Sepsis Among Patients With Versus Without Comorbid Heart Failure/ J. King, Ann Arbor, MI P1202 Sepsis-induced Increases in Blood Acetylcarnitine Reflect Organ-level Energy Disruption That Is Improved by Supplemental L-carnitine/ K.A. Stringer, Ann Arbor, MI P1203 The Impact of Aging on Sepsis-related Endothelial Glycocalyx Degradation/ R. Sullivan, Aurora, CO P1204 Impact of Positive Fluid Balance on Each Day of the First Three Days of ICU in Patients With Sepsis/ D.-G. Hyun, Seoul, Korea, Republic of P1205 Creation and Validation of Novel Actionable Sepsis Phenotypes Using Clinical Data/ G. Wardi, San Diego, CA P1206 Association of Estimated Plasma Volume Status With Clinical Outcomes in Patients With Sepsis/ S. Isha, Jacksonville, FL

ATS 2023 • Washington, DC